[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Leddy JJ, Haider MN, Ellis MJ, et al
Scand J Haematol 1977;19:453-62
Not for human or animal consumption, clinical, therapeutic, cosmetic, or veterinary use
Because AOD9604 is not FDAapproved and cannot be compounded under current guidance, it is offered only under a strict informed consent framework with full transparency about its investigational status, potential risks, and mixed efficacy data
Qualified professionals looking to include either AOD-9604 or ipamorelin in their studies are advised to source from a reliable online vendor.
For those willing to accept this level of uncertainty, the risk-benefit calculation may still favor trying BPC-157, especially given its favorable safety profile and the limited options for chronic back pain sufferers